The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung cancer
Open Access
- 21 February 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 6 (1), 1-3
- https://doi.org/10.1038/s41392-020-00452-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung CancerJournal of Thoracic Oncology, 2016
- Prognosis of synchronous and metachronous multiple primary lung cancers: Systematic review and meta-analysisLung Cancer, 2015
- Epidermal growth factor receptor‐tyrosine kinase inhibitor therapy is effective as first‐line treatment of advanced non‐small‐cell lung cancer with mutated EGFR: A meta‐analysis from six phase III randomized controlled trialsInternational Journal of Cancer, 2011
- Management of Multiple Pure Ground-Glass Opacity Lesions in Patients with Bronchioloalveolar CarcinomaJournal of Thoracic Oncology, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009